We have observed a strong trend toward more NRF2 highly stained tumors within the TP53/CNH-like group, known to be of poor prognosis [2], consistent with previous reports describing higher NRF2 expression with advanced stage and high tumor grade in endometrial carcinomas [32]. This evidence concerns the gene TP53 and endometrial carcinoma.